Many companies believe that by combining their medical devices or drug-delivery systems with connected capabilities, they can boost patient compliance and learn more about the products they have on
Many companies believe that by combining their medical devices or drug-delivery systems with connected capabilities, they can boost patient compliance and learn more about the products they have on
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.